HOW CANCER WORKS
PUBLISHED ONCOLOGY STUDIES.
DEUTERIUM INTERFERES WITH DNA'S ABILITY TO PROPERLY FOLD AND REPLICATE
What Deuterium Does in DNA.
When deuterium becomes part of the sugar backbone of your DNA, it can change its three dimensional structure - the more deuterium that's in it, the bigger the change. Think of it like Lego pieces, the shape of what you create depends on the size of the pieces you use. When the change becomes too big it doesn’t allow the DNA to fold properly.
If it can't fold then the DNA remains stretched out and the cell continually replicates and never stops to mature and grow old like normal cells. Continuous replication also means that there are more chances for mistakes which scientists call mutations. Mutations can lead to cancer cells that are even more aggressive and resistant to the usual bevy of chemo, radiation, and oncological medicines.
How Deuterium Depletion Helps.
Deuterium depletion:
- Lowers the amount of deuterium available to your DNA.
- Depletes deuterium from your existing DNA and allows it to fold properly.
- Gives you the right Lego pieces to make "good DNA."
- Stops the high rate of mutations in cancer cells and, therefore, increases the effectiveness of drugs - even those that didn't work at first.
- Allows cells to stop replicating and mature like normal cells - all normal cells die a natural death called apotosis.
DEUTERIUM FUELS CANCER CELLS AND MAKES THEM GROW.
What Deuterium Does in Cancer Metabolism.
Almost everyone knows that cancer cells need carbs (sugar) to grow. What most don't know is that it's not actually the carbs themselves but the deuterium on the carbs. The metabolism of both normal and cancer cells use the hydrogens from the food we eat to make energy using the tiny nanomotors in our mitochondria. But these delicate motors are broken when they use deuterium rather than hydrogen as fuel. Normal cells become cancerous by switching to alternative metabolic pathways to make the energy they need. The problem is that cancer cells need a lot more "fuel" because, unlike normal cells, they're "always" growing, dividing, and making more cancer cells! Having high levels of deuterium is literally like pouring gas into your cancer's fuel tank.
How Deuterium Depletion Helps.
Deuterium depletion:
- Lowers the amount of deuterium in your cells.
- Lessens the ability of cancer cells to make the energy they need to continually grow and divide via the alternative metabolic pathways.
- Takes away the energy cancer cells need to metastasize.
DEUTERIUM DYSREGULATES YOUR IMMUNE SYSTEM AND ALLOWS INFECTIONS TO GROW.
What Deuterium Does in Infections.
Inflammation, a deuterium related event, is always present in cancers. It leads to immune system dysregulation and the initiation of responses to "non harmful" entities in the body that would otherwise be ignored. The confused immune system then becomes worn out and incapable of mounting an effective response to "harmful" entities when they do arise. A common clinical finding in cancer is increased infections from fungus, bacteria, viruses, and protozoa. Many patients die from these infections and not the cancer itself. Every one of these infectious organisms have their nanomotors pointing in the opposite direction as the ones inside our mitochondria. As a consequence, their nanomotors drive deuterium and not hydrogen into their mitochondria to make energy! This means that the same high amount of deuterium needed to drive cancer cell growth is also available to drive the growth of harmful infections.
How Deuterium Depletion Helps.
Deuterium depletion:
- Lowers the amount of deuterium in your body.
- Lessens the availability of deuterium to dysregulate and turn off the immune system.
- Lessens the availability of deuterium that infectious pathogens like bacteria, viruses, fungus, and protozoa need to grow.
- Mitigates the growth of existing infections while stopping the occurrence of new infections.
SAMPLE CLINICAL RESEARCH STUDIES ON CANCER
More than 7,000 cancer patients have used Preventa Deuterium Depleted Water as a complementary or standalone therapy. This section contains summary studies for lung, prostate, breast, and pancreatic cancers. These are scientific papers and may be a little difficult for some laypeople. The bottom line is that the treatment group patients in each study consumed DDW but their standard of care treatment, diet, and lifestyle habits were not controlled. Regardless of that, all four studies demonstrate that DDW consumption results in better than expected clinical outcomes and longer cancer-free living for lung, prostate, breast, and pancreatic cancers no matter the stage of the cancer.
PROSTATE CANCER
In addition, beside the 44 evaluated patients in the phase 2 clinical trial, the course of the disease was also retrospectively evaluated in 91 patients consuming DDW parallel with the conventional forms of treatment. 20 out of 91 retrospectively followed patients developed distant metastasis within one year after the diagnosis. The median survival time (MST) was 5.4 year, while the historical control is 1.2-1.6 years.
The results suggest that DDW might reduce the mortality of prostate cancer, since it was able to delay progression as well as to prolong MST in patients with histologically confirmed prostate cancer.
References:
A. Kovács, I. Guller, K. Krempels, I. Somlyai, I. Jánosi, Z. Gyöngyi, Szabó, I. Ember and Gábor Somlyai (2011) Deuterium Depletion May Delay the Progression of Prostate Cancer. Journal of Cancer Therapy 2, 548-556.
Somlyai, A. Kovács, I. Guller, Z. Gyöngyi, K. Krempels, I. Somlyai, M. Szabó, Berkényi, M. Molnár (2010) Deuterium has a key role in tumour development – new target in anticancer drug development. European Journal of Cancer 8(5):208.
Somlyai, G. Jancsó, Gy. Jákli, T. Berkényi, Z. Gyöngyi, I. Ember (2001) The Biological Effect of Deuterium Depleted Water, a Possible New Tool in Cancer Therapy. Anticancer Research 21:1617
BREAST CANCER
References:
K. Krempels, I. Somlyai, Z. Gyöngyi, I. Ember, K. Balog, O. Abonyi, G. Somlyai (2013) A retrospective study of survival in breast cancer patients undergoing deuterium depletion in addition to conventional therapies. Journal of Cancer Research & Therapy 2013, 1(8):194–200.
K. Krempels, I. Somlyai, K. Balog, G. Somlyai (2012) A retrospective study of survival in breast cancer patients undergoing deuterium-depletion in addition to the conventional therapies. Abstract in: 2nd International Congress on Deuterium Depletion European Chemical Bulletin, 1(1-2), 46-47.
G. Somlyai (2004) A deutérium depletio hatása IV. stádiumban lévő, emlőtumoros betegek várható túlélésére/Deuterium Depletion and its Impact on Life Expectancy of Patients with Stage IV breast tumor. Komplementer Medicina/Journal of Complementary and Alternative Medicine VIII (4):30-35.
LUNG CANCER
From the data of the 129 patients involved, median survival increased for men from the expectable 7.5 to 25.9 months, and for women, from 11.3 to 74.1 months as a result of supplementary DDW application; while in the average for both sexes, median survival was 33.7 months. In cases of non-small cell lung cancer with brain metastasis, expectable median survival time is usually 19 to 27 months, but in our study it was 31.1 for both sexes.
Application of DDW thus prolonged the expectable median survival time of lung cancer patients 2 to 4- fold, compared to the patient population not consuming DDW. In certain cases, several years of survival or even complete remission was observed instead of the clinically expected few months. The cases of four lung cancer patients with brain metastasis who consumed DDW have been presented in our paper published in the Journal of Cancer Therapy.
References:
Z. Gyöngyi, F. Budán, I. Szabó, I. Ember, I. Kiss, K. Krempels, I. Somlyai, G. Somlyai (2012) Deuterium Depleted Water Effects on Survival of Lung Cancer Patients and Expression of Kras and Bcl2 Genes in Mouse Lung. Nutrition and Cancer, 65:2, 240-246.
K. Krempels, I. Somlyai and Gábor Somlyai (2008) A retrospective evaluation of the effects of deuterium depleted water consumption on four patients with brain metastases from lung cancer. Integrative Cancer Therapies 7(3):172-81
PANCREATIC CANCER
DDW inhibited the growth of MIA PaCa-2 pancreas tumor cells in vitro. Applied together with conventional therapy, DDW prolonged MST of patients with progressive, inoperable pancreatic cancer 4-6 times.
Reference:
Boros L.G., Meuillet E.J., Somlyai I., Jancsó G., Jákli G., Krempels K., Puskás L.G., Nagy L., Molnár M., Laderoute K.R., Thompson P.A., Somlyai G. (2014) Fumarate hydratase and deuterium depletion control oncogenesis via NADPH-dependent reductive synthesis. AACR 2014 - Annual Meeting, April 5-9, San Diego, CA, USA, DOI: 10.12918/HYD2014AACRPOST
FDA DISCLAIMER
FOOD AND DRUG ADMINISTRATION STATEMENT
The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. These statements and the products and services of this company are not intended to diagnose, treat, cure, or prevent any disease.
LEGAL DISCLAIMER
Please consult your physician before implementing any new diet, exercise, and dietary supplement programs, especially if you have preexisting medical conditions or are taking prescribed medications. The statements made on this website are for educational purposes only and are not meant to replace the advice of your physician or healthcare provider.